Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Cardiovasc Med (Hagerstown) ; 15(1): 60-7, 2014 Jan.
Article de Anglais | MEDLINE | ID: mdl-24500238

RÉSUMÉ

AIMS: We evaluated the effect of different dose hydration protocols, with normal saline or bicarbonate, on the incidence of contrast-induced acute kidney injury (CI-AKI) in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PPCI). METHODS: We considered 592 STEMI patients treated with PPCI in 5 Italian centers. Patients were randomized to receive standard or high-dose infusions of normal saline or sodium bicarbonate started immediately before contrast medium administration and continued for the following 12 h. RESULTS: The cumulative incidence of CI-AKI was 18.1% without any difference among treatment groups. Shock, age, ejection fraction 35% or less, and basal serum creatinine were significantly associated with an increased risk of CI-AKI. Follow-up at 12 months was complete in 573 patients. Overall, 25 out of 573 patients died (4.3%). We observed higher short-term mortality rates in patients receiving high-volume hydration. Otherwise, only age, shock and CI-AKI were significantly associated with 1-year mortality. CONCLUSION: In patients with STEMI undergoing PPCI, high-volume hydration with normal saline or sodium bicarbonate administrated at the time of contrast media administration was not associated with any significant advantage in terms of CI-AKI prevention.


Sujet(s)
Atteinte rénale aigüe/prévention et contrôle , Traitement par apport liquidien/méthodes , Infarctus du myocarde/thérapie , Intervention coronarienne percutanée/effets indésirables , Hydrogénocarbonate de sodium/administration et posologie , Chlorure de sodium/administration et posologie , Atteinte rénale aigüe/diagnostic , Atteinte rénale aigüe/étiologie , Atteinte rénale aigüe/mortalité , Sujet âgé , Produits de contraste/effets indésirables , Femelle , Traitement par apport liquidien/effets indésirables , Traitement par apport liquidien/mortalité , Humains , Incidence , Perfusions parentérales , Italie , Mâle , Adulte d'âge moyen , Infarctus du myocarde/diagnostic , Infarctus du myocarde/mortalité , Intervention coronarienne percutanée/mortalité , Facteurs de risque , Facteurs temps , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE